Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer External Web Site Icon WA Woordward et al, JAMA Oncology, January 9, 2020

Hot Topics of the Day|PHGKB

What's New

Last Posted: Jan 10, 2020

---

• Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer 
  WA Woordward et al, JAMA Oncology, January 9, 2020
• Introducing the Personal Genomics Podcast 
  NCI, January 2020
• A primer on the genetics of medullary thyroid cancer. 
  Larouche V et al. Current oncology (Toronto, Ont.) 2019 Dec 26(6) 389-394
• FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms. 
  Lu Wei et al. Cancer medicine 2020 Jan
• Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. 
  Dai Gong-Peng et al. Oncology letters 2020 Jan 19(1) 388-398
• Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer. 
  Cavallaro Paul et al. Clinical colorectal cancer 2019 Dec
• International evaluation of an AI system for breast cancer screening. 
  McKinney Scott Mayer et al. Nature 2020 577(7788) 89-94
• The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review. 
  Van Paemel Ruben et al. European journal of pediatrics 2020 Jan
• New PARP Inhibitor Approval for Pancreatic Cancer 
  L Schlager, FORCE, January 6, 2020
• Telling Your Children About Inheritable Cancer Risk 
  MA Landsmann, Cancer Today, December 2019
• Data Sharing for the Public Good. 
  Helzlsouer Kathy J et al. Journal of the National Cancer Institute 2020 Jan
• Genetic factors, adherence to healthy lifestyle behavior, and risk of invasive breast cancer among women in the UK Biobank. 
  Arthur Rhonda S et al. Journal of the National Cancer Institute 2020 Jan
• Moving Molecular Profiling to Routine Clinical Practice: A Way Forward? 
  Freidlin Boris et al. Journal of the National Cancer Institute 2019 Dec
• No multiplicative GXE interactions for breast cancer risk: Have we reached a verdict or is the jury still out? 
  Terry Mary Beth et al. International journal of epidemiology 2019 Dec
• AI shows promise for breast cancer screening 
  ED Pisano, Nature, January 2020